Can the UK Become a Global Hub for Oncology Clinical Trials Again? A 25-year perspective on cancer research in the UK, the EU, the USA and China.
Clinical trials reflect a country's scientific capability, regulatory efficiency, healthcare infrastructure and ability to attract global investment. In oncology, innovation is moving at exceptional speed, and the competition to host the clinical trials has become increasingly international.